Neuphoria Therapeutics Inc. Adjustments For Increase Decrease In Trade Account Payable
Neuphoria Therapeutics Inc. (NEUP) reported Adjustments For Increase Decrease In Trade Account Payable of AUD 714.21 thousand for the 12-month period ending 2023-06-30, per its 20-F filed 2023-10-18.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2023-10-18
| Period end | Adjustments For Increase Decrease In Trade Account Payable 12 month |
|---|---|
| 2023-06-30 | 714.21K AUD 20-F · filed 2023-10-18 |
| 2022-06-30 | 979.90K AUD 20-F · filed 2023-10-18 |
| 2021-06-30 | -63.30K AUD 20-F · filed 2023-10-18 |
| 2020-06-30 | 127.45K AUD 20-F · filed 2022-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |